Education
About Us
Working with TipRanks
Follow Us
Vertex Pharmaceuticals Inc. (VRTX)
NASDAQ:VRTX
Suzetrigine, Vx-548, Suz
Pain
Phase I
Recruiting
Evaluation of the Excretion of Suzetrigine Into Breast Milk in Healthy Lactating Female Participants
Jan 23, 2026
―
Vx-407
Autosomal Dominant Polycystic Kidney Disease (Adpkd)
Phase I
Completed
A Phase 1 Study Evaluating Safety, Tolerability, and Pharmacokinetics of VX-407 in Healthy Participants
Jun 06, 2025
―
Povetacicept
Healthy Volunteers
Phase I
Completed
A Study to Evaluate the Relative Bioavailability of Povetacicept Formulations and Bioequivalence of Povetacicept Presentations
May 30, 2025
―
FAQ
What are the FDA phases for drug approval?
The FDA approval process for new drugs is divided into several phases:
a. Preclinical testing
b. Phase 1 – Safety and dosage
c. Phase 2 – Effectiveness and side effects
d. Phase 3 – Confirmation of effectiveness, monitoring of adverse reactions, and comparison with existing treatments
e. Phase 4 – Post-marketing studies to track long-term safety and effectiveness
a. Preclinical testing
b. Phase 1 – Safety and dosage
c. Phase 2 – Effectiveness and side effects
d. Phase 3 – Confirmation of effectiveness, monitoring of adverse reactions, and comparison with existing treatments
e. Phase 4 – Post-marketing studies to track long-term safety and effectiveness
What is a clinical trial?
A clinical trial is a carefully designed study in which researchers test a drug, treatment, or medical device in people to evaluate its safety, effectiveness, and potential side effects. These trials are essential for determining whether a new treatment should be approved for widespread use.
What drugs does Vertex Pharmaceuticals Inc. (VRTX) have in its pipeline
VRTX is currently developing the following drugs: Suzetrigine, Vx-548, Suz, Suzetrigine, Tacrolimus, Povetacicept. These drug candidates are in various stages of clinical development as the company works toward FDA approval.